Diagnos Inc (ADK : TSX-V)
Common Stock
$0.23
CAD
-0.00 (-1.10%)
Last updated: 2026-06-25
ADK
Diagnos Inc
WealthAwesomePerformance
1 Day
-1.10%
1 Week
+0.00%
1 Month
+2.27%
YTD
-37.50%
Key Statistics
Market Cap
$27.09M
52W High
$0.42
52W Low
$0.18
P/E Ratio
-
50 Day MA
$0.22
200 Day MA
$0.29
Beta
-0.16
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/25/2026 | $0.23 | $0.23 | $0.21 | $0.23 | $0.23 | 140,400 |
| 6/24/2026 | $0.23 | $0.23 | $0.22 | $0.23 | $0.23 | 60,842 |
| 6/23/2026 | $0.23 | $0.23 | $0.22 | $0.23 | $0.23 | 44,066 |
| 6/22/2026 | $0.23 | $0.23 | $0.21 | $0.23 | $0.23 | 86,490 |
| 6/19/2026 | $0.23 | $0.23 | $0.21 | $0.23 | $0.23 | 88,770 |
| 6/18/2026 | $0.23 | $0.23 | $0.20 | $0.23 | $0.23 | 204,572 |
| 6/17/2026 | $0.20 | $0.25 | $0.20 | $0.22 | $0.22 | 648,000 |
| 6/16/2026 | $0.20 | $0.20 | $0.19 | $0.20 | $0.20 | 83,667 |
| 6/15/2026 | $0.20 | $0.20 | $0.19 | $0.20 | $0.20 | 46,500 |
| 6/12/2026 | $0.20 | $0.20 | $0.20 | $0.20 | $0.20 | 72,500 |
Analyst Price Targets
Based on analyst covering ADK
Wall Street analysts forecast ADK stock price to rise 566.7% over the next 12 months.
Consensus
No RatingAvg. Target
C$1.50
+566.7% Upside
Current Price
C$0.23
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ADK's historical volatility
30-Day Vol
67.5%
Annualized
90-Day Vol
50.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.19
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.21 | C$0.17 โ C$0.27 |
| 60 trading days | C$0.20 | C$0.14 โ C$0.28 |
| 90 trading days | C$0.19 | C$0.13 โ C$0.28 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Diagnos Inc
DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialists to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.
Financials
- Revenue (TTM)
- $65,478
- EBITDA
- $-4.25M
- Profit Margin
- 0.00%
- ROE (TTM)
- -990.25%
- EPS (Diluted)
- -0.04
- Book Value
- 0.01
Classification
- Sector
- Health Care
- Industry
- Health Care Technology
- Group
- Health Care Equipment & Services
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About ADK
Articles Featuring ADK.V
Latest articles and analysis covering ADK.V
